1. Home
  2. TMDX vs IMOS Comparison

TMDX vs IMOS Comparison

Compare TMDX & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$66.78

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

IMOS

ChipMOS TECHNOLOGIES INC.

HOLD

Current Price

$69.50

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
IMOS
Founded
1998
1997
Country
United States
Taiwan
Employees
N/A
5823
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
TMDX
IMOS
Price
$66.78
$69.50
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$148.22
N/A
AVG Volume (30 Days)
1.8M
92.7K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
1.51%
EPS Growth
382.18
N/A
EPS
0.20
N/A
Revenue
$605,494,000.00
N/A
Revenue This Year
$24.25
$21.75
Revenue Next Year
$18.75
$4.21
P/E Ratio
$341.18
$158.35
Revenue Growth
37.13
N/A
52 Week Low
$60.11
$15.06
52 Week High
$156.00
$67.25

Technical Indicators

Market Signals
Indicator
TMDX
IMOS
Relative Strength Index (RSI) 31.32 75.83
Support Level $60.11 $33.51
Resistance Level $120.60 N/A
Average True Range (ATR) 3.81 2.55
MACD 1.43 1.29
Stochastic Oscillator 61.30 96.44

Price Performance

Historical Comparison
TMDX
IMOS

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

Share on Social Networks: